Search results
Pfizer reports dip in first quarter profits, yet beats estimates
dpa international via Yahoo Finance· 19 hours agoThe US pharmaceutical giant Pfizer on Wednesday said its earnings for the first quarter had declined...
Pfizer Stock Rises as Outlook Raised After Earnings Beat
Barrons.com· 23 hours agoPfizer reports first-quarter adjusted earnings of 82 cents a share on revenue of $14.88 billion.Read...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 1 day agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...
Pfizer: Q1 Earnings Snapshot
Midland Reporter-Telegram· 24 hours agoNEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Wednesday reported first-quarter...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 2 days agoPfizer and Genmab’s Tivdak (tisotumab vedotin-tftv) has won full approval from the US Food and Drug...
Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 6 days agoBeyond analysts' top -and-bottom-line estimates for Pfizer (PFE), evaluate projections for some of...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 24 hours agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
Analyst Report: Pfizer Inc.
Morningstar Research via Yahoo Finance· 17 hours agoPfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types ...
My Top 5 Favorite High-Yield Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 41 minutes agoThe company has a strong balance sheet with solid credit ratings. It's also investing in building...
Pfizer Reportedly Plans D2C COVID and Migraine Drug Platform
PYMNTS.com· 18 hours agoPharmaceutical giant Pfizer is reportedly creating an online platform selling anti-COVID and...